Free Standard AU & NZ Shipping For All Book Orders Over $80!
Register      Login
Reproduction, Fertility and Development Reproduction, Fertility and Development Society
Vertebrate reproductive science and technology
RESEARCH ARTICLE

135 REGULATION OF GLUCOSE METABOLISM TO DECREASE LIPID CONTENT OF IN VIRTO-PRODUCED BOVINE EMBRYOS

J. De La Torre-Sanchez A , D. Gardner B , K. Preis B and G. Seidel Jr A
+ Author Affiliations
- Author Affiliations

A Animal Reproduction and Biotechnology Laboratory, Colorado State University, Fort Collins, CO 80521, USA

B Colorado Center for Reproductive Medicine, Englewood, CO 80110, USA. Email: gseidel@colostate.edu

Reproduction, Fertility and Development 17(2) 218-218 https://doi.org/10.1071/RDv17n2Ab135
Submitted: 1 August 2004  Accepted: 1 October 2004   Published: 1 January 2005

Abstract

Our objective was to improve normality of embryos produced in vitro with regulators of carbohydrate metabolism at doses optimized in earlier experiments. Eight- to 16-cell embryos were produced in vitro in the G1/G2 system (chemically defined sequential medium with recombinant human serum albumin), and then cultured 3 days in G2 containing metabolic regulators as follows: phenazine ethosulfate (PES), 0.3 μM; NaN3, 27 μM; 2,4-dinitrophenol (DNP), 30 μM; and control. The following responses were analyzed by ANOVA in 2 to 4 replicates of 8–12 embryos each: glucose uptake and metabolism (uptake measured by microfluorometry of medium after incubating an embryo 3 h; metabolism measured as 3H2O released after incubating an embryo 3 h in medium containing 5-3H glucose), % of glucose metabolized via the pentose phosphate pathway (PPP rate), lactate production, glycolysis (% of lactate produced from glucose taken up on a molar basis), lipid accumulation (number of >2 μM Sudan Black B positive granules/103 μm2), % live Day 14 embryos recovered from embryos transferred to recipients at Day 7, and average surface area of embryos collected. In vivo-derived embryos were included as a second control for lipid evaluation. PES-treated embryos had higher glucose metabolism (P < 0.05) and lower glucose uptake (P < 0.01) than embryos in NaN3 and tended to have a higher PPP rate (P < 0.11) than controls; however, glycolysis was higher for PES than other treatments (P < 0.01) (Table 1). Lipid accumulation of embryos from PES was markedly lower than any other in vitro treatments (P < 0.01), but higher than in vivo embryos (3.31 ± 2.78 lipid granules) (P < 0.01). NaN3- and DNP-treated embryos both accumulated lipid similar to in vitro controls. No treatment differences were found in developmental competence when Day 7 embryos were transferred to recipients and recovered 1 week later (43 to 54% live embryos recovered), nor were there any significant differences (P > 0.1) in surface area. Embryos exposed to PES at the compaction and post-compaction stages accumulated much less lipid than controls or embryos exposed to other metabolic regulators, making this a very promising treatment. PES oxidizes NADPH; the molecular mechanism of PES appears to involve increased flux of glucose through the PPP while decreasing availability of NADPH for fatty acid synthesis.


Table 1.
Response of embryos to metabolic regulators
T1